• 1. Excess electrons in lithium–ethylamine solutions—density, electrical conductivity and EPR studies
  Phys. Chem. Chem. Phys., 1999,1, 3561-3565
• 2. Emerging investigator series: kinetics of diopside reactivity for carbon mineralization in mafic–ultramafic rocks
  BrianaAguila,LandonHardee,H.ToddSchaef,SiavashZare,MohammadJavadAbdolhosseiniQomi,JarrodV.Crum,JadeE.HollimanJr.,ElenaTajueloRodriguez,LawrenceM.Anovitz,KevinM.Rosso,QuinR.S.Miller
• 3. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 4. Emerging investigator series: first-principles and thermodynamics comparison of compositionally-tuned delafossites: cation release from the (001) surface of complex metal oxides?
  Joseph W. Bennett,Diamond T. Jones,Blake G. Hudson,Joshua Melendez-Rivera,Robert J. Hamers,Sara E. Mason Environ. Sci.: Nano, 2020,7, 1642-1651
• 5. Exciting clusters, what does off-resonance actually mean??
  Goonay Yousefalizadeh,Shideh Ahmadi,Nicholas J. Mosey,Kevin G. Stamplecoskie Nanoscale, 2021,13, 242-252

Professional Introduction to 4-(2-Phenoxyethoxy)aniline (CAS No. 35965-96-9)

4-(2-Phenoxyethoxy)aniline, identified by its CAS number 35965-96-9, is a significant compound in the field of pharmaceutical chemistry and biochemistry. This compound, featuring a phenoxyethoxy substituent attached to an aniline backbone, has garnered attention due to its potential applications in drug development and molecular research. The unique structural attributes of this molecule make it a valuable candidate for further exploration in various scientific domains.

The chemical structure of 4-(2-Phenoxyethoxy)aniline consists of a phenyl ring linked to an ethoxy group, which is further connected to an aniline moiety. This configuration imparts specific electronic and steric properties that can be exploited in the design of novel therapeutic agents. The presence of the phenoxyethoxy group enhances the solubility and bioavailability of the compound, making it a promising candidate for oral or injectable formulations.

In recent years, there has been growing interest in the development of molecules that can modulate biological pathways associated with neurological disorders. 4-(2-Phenoxyethoxy)aniline has been studied for its potential role in affecting neurotransmitter systems, particularly those involving dopamine and serotonin. Preliminary research suggests that this compound may exhibit properties similar to selective serotonin reuptake inhibitors (SSRIs), although further studies are necessary to confirm these findings.

The synthesis of 4-(2-Phenoxyethoxy)aniline involves multi-step organic reactions, typically starting from readily available precursors such as aniline and phenoxyethanol. Advanced synthetic techniques, including palladium-catalyzed cross-coupling reactions, have been employed to achieve high yields and purity. These methods align with the industry's push towards greener and more efficient synthetic pathways, ensuring minimal environmental impact.

One of the most compelling aspects of 4-(2-Phenoxyethoxy)aniline is its potential in drug discovery. The compound's ability to interact with biological targets makes it a versatile scaffold for medicinal chemists. By modifying its structure, researchers can fine-tune its pharmacological properties, leading to the development of more effective and targeted therapies. This flexibility is particularly valuable in the quest to combat resistant strains of pathogens and diseases.

The pharmaceutical industry has increasingly relied on computational modeling and high-throughput screening to identify promising candidates like 4-(2-Phenoxyethoxy)aniline. These approaches allow for rapid evaluation of thousands of compounds based on their predicted interactions with biological targets. The integration of machine learning algorithms has further enhanced the accuracy of these predictions, reducing the time and cost associated with drug discovery.

In addition to its pharmaceutical applications, 4-(2-Phenoxyethoxy)aniline has shown potential in materials science. Its unique chemical properties make it suitable for use in organic electronics and sensors. For instance, it can be incorporated into conductive polymers that exhibit high charge carrier mobility, which is crucial for developing flexible electronics and advanced display technologies.

The safety profile of 4-(2-Phenoxyethoxy)aniline is another critical consideration. Extensive toxicological studies are required to assess its potential side effects and determine safe exposure levels. These studies often involve in vitro and in vivo experiments to evaluate acute and chronic toxicity. The results from these studies are essential for ensuring that the compound can be used safely in both laboratory settings and clinical applications.

The regulatory landscape for new chemical entities like 4-(2-Phenoxyethoxy)aniline is stringent but well-established. Regulatory agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) require comprehensive data on a compound's safety, efficacy, and quality before approving it for medical use. This rigorous process ensures that only well-researched and validated drugs reach the market.

Future research directions for 4-(2-Phenoxyethoxy)aniline include exploring its mechanisms of action in greater detail. Understanding how this compound interacts with biological targets at a molecular level can provide insights into its therapeutic potential and limitations. Additionally, investigating its pharmacokinetic properties will help optimize dosing regimens and improve patient outcomes.

The role of collaboration in advancing research on compounds like 4-(2-Phenoxyethoxy)aniline cannot be overstated. Multi-disciplinary teams comprising chemists, biologists, pharmacologists, and clinicians work together to translate basic research findings into tangible therapeutic benefits. Such collaborations foster innovation and accelerate the development of new treatments for various diseases.

In conclusion, 4-(2-Phenoxyethoxy)aniline (CAS No. 35965-96-9) is a multifaceted compound with significant potential in pharmaceuticals, materials science, and beyond. Its unique structure and properties make it a valuable tool for researchers seeking to develop new therapies and technologies. As scientific understanding continues to evolve, compounds like this will play an increasingly important role in addressing global health challenges.

• 6421-88-1(2-(4-aminophenoxy)ethanol)
• 725237-15-0(Benzenamine,3-methoxy-5-(2-methoxyethoxy)-)
• 6954-41-2(Benzenamine,4,4'-[oxybis(2,1-ethanediyloxy)]bis-)
• 109690-44-0(Aniline,4,4'-(ethylenedioxy)di-, dihydrochloride (6CI))
• 84649-40-1(Benzenamine,4,4'-[3,6,9,12,15-pentaoxaheptadecane-1,17-diylbis(oxy)]bis-)
• 6052-10-4(4,4'-(Ethane-1,2-diylbis(oxy))dianiline)
• 82959-75-9(Benzenamine,4,4'-[3,6,9,12,15,18,21-heptaoxatricosane-1,23-diylbis(oxy)]bis-)
• 33311-29-4(4-(2-Methoxyethoxy)aniline)
• 110178-35-3(3-(2-Methoxyethoxy)phenylamine)
• 25940-46-9(3,3'-[1,2-Ethanediylbis(oxy)]bisbenzenamine)